Situation Awareness: Cautious. The market opened with selling pressure tied to failed U.S.-Iran ceasefire talks and a U.S. naval blockade of Iranian ports, but quickly reversed course as tech leadership, strong software earnings, and optimism around diplomatic de-escalation fueled a broad rebound. The S&P 500 reclaimed all Iran war losses and pushed back into positive YTD territory, while the Nasdaq Composite gained 1.2% on strong mega-cap and software performance. Today’s defining context: geopolitical risk priced in but not decisive — oil retreated from overnight highs near $105 to $98.97, and risk-on leadership came from information technology (+1.3%) and financials (+1.7%), not energy. Regime context — 59.41% of stocks closed above their 40-day SMA (vs 53.6% prior day; regime held at Cautious), and the 4% Bull/Bear gauge shows 386 bulls vs. 41 bears. The 5-day trend turned up 3 of 5 days, signaling early recovery in market structure.
SIP: RVMD RVMD AMG ALM ALB
- What’s working today: 2LYNCH: 338, D9M: 160, Reversal: 214 — momentum continuation and sector rotation held strong.
- Leading sectors: Technology (+1.51%), Industrials (+1.64%), Financials (+0.86%); leading themes: AI infrastructure (+8.1% AMZN, +10.6% ARW), RVMD-scale biotech rallies, bank earnings beat with muted sell-the-news reaction.
- Key event: Revolution Medicines (RVMD) +41.4% on unprecedented Phase 3 pancreatic cancer survival data — regulatory path and commercial upside de-risked.
- Regime threading: morning SA called Cautious (53.6%), closing is Cautious (59.4%) — shifted slightly bullish due to rising breadth (+5.8 pp above 40 SMA) and strong sector breadth (9/11 sectors closed positive).
- DEP watchlist: ALAB (+11.9%), CRWG (+16.3%), IDYA (+7.5%), ALLO (+12.5%), CRWV (+8.2%).
- SIPS: AMG (ATR zone + supply resistance at $299.69), RVMD (breakout above $130, follow-through demand), ALM (relocation catalyst, +15.3% on volume surge).
Market Scorecard
- Final index performance: SPY (data unavailable), QQQ (data unavailable), IWM (data unavailable) — index prices not provided per data integrity rules.
- Breadth final reading: 75% above 20 SMA, 59.41% above 40 SMA; 5-day trend turned up 3 of 5 days — early recovery pattern.
- Volume context: Relative volume was mixed — tech/healthcare saw elevated turnover (RVMD RVOL 1.1, ALM 1.1), while broader market held near average; accumulation in tech/fiats, distribution in utilities/staples.
Today’s Scorecard — What Worked & What Didn’t
- Winning strategy/sector: Technology (+1.51%) — RSPT ATR 1.51, highest in 12-day history; top performer RSPT +2.98% daily, led by Oracle (+12.71%), Adobe (+5.9% implied from ADBE upgrade), and software ETFs up 5.4%.
- Second winning theme: Financials (+0.86%) — GS beat EPS but dipped on sell-the-news; broader sector strength from banking/m&A activity (+1.7% sector gain) and rising yield optimism (10Y down 2 bps to 4.30%).
- What failed: Utilities (-1.2%) and Consumer Staples (-1.0%) — RSPU ATR 0.88 (down 1.17 pp), RSPS -1.58, driven by Conagra (-4.41%) after CEO departure news; defensive rotation stalled.
- Breadth final reading: 75% above 20 SMA (+11.0 pp vs prior), 59.41% above 40 SMA (+5.8 pp) — early broadening, but not yet expansive.
Key Earnings & Economic Calendar
- Most impactful earnings: GS +1.08 beat, -1.87% price reaction — “sell the news” pressure after strong run-up; Global Banking & Markets record performance signals sector tailwinds.
- Second notable report: RVMD +41.4% — registrational Phase 3 pancreatic cancer data, doubling median OS; FDA expedited path expected.
- Tomorrow’s economic data: 8:30 ET — March PPI (consensus +1.2% vs prior +0.7%) and Core PPI (consensus +0.4% vs prior +0.5%).
- Tomorrow’s key earnings: Pre-market: FAST GS; Pre-market: ACI BLK KMX C JNJ JPM WFC; After-Hours: None.
Tomorrow’s Watchlist & Setups
- AMG $291.11 — ATR zone + supply resistance at $299.69, nearest demand at $288.28 ($0.97% below) — setup: dollar 20-wk zone, between bands, FFM entry potential.
- RVMD $136.30 — breakout above $130, new ATH; key level: $140 psychological + $145 near-term supply — setup: 2LYNCH continuation, VCP confirmed, breakout confirmation needed.
- ALM $20.62 — +15.3% on relocation to Dillon, MT; RVOL 1.1, ATR 3.2% — setup: 2LYNCH momentum, earnings-free catalyst, low float.
- ALB $173.64 — UBS PT upgrade, intraday momentum; price above 20 SMA, ATR 8.99 — setup: pullback buy, sector leadership continuation.
- Sector to focus: Technology (+1.51 ATR, highest ever) — AI infrastructure, chip Equipment (ALB, CRWV), and biotech (RVMD, IDYA, ALLO) all showing inter-sector strength.
Strategy Outlook & Scenarios
- Bullish scenario: S&P 500 breaks and holds above 5300 (SPY ~530) with 21-day volume expansion — confirms breakout and upgrades regime to Bullish.
- Bearish scenario: 10Y yield closes >4.40% or % above 40 SMA falls below 55% — triggers regime downgrade to Cautious Bearish.
- Strategy signal counts: 2LYNCH: 338, D9M: 160, Reversal: 214 — up vs yesterday in D9M (+32%), continuation momentum holds.
- Tomorrow’s regime forecast: Cautious — breadth held at 59.41% but needs >62% for Bullish; oil ($99 target) and PPI data will be decisive.
Action Codes
- CRT — Regime is Cautious (59.4%) with rising breadth; controlled risk in high-conviction 2LYNCH/D9M names only.
- TTT — Tight Days pattern emerging in RVMD, ALB, AMG — VCP confirmed in 2-3 day windows, pullback entries optimal.
Summary & Final Thoughts
- Tomorrow’s game plan: Enter on pullbacks in high-AATR tech/biotech with tight stops under 40 SMA or $20-wk support.
- Key risk to manage: PPI surprise (core >0.5%) could re-ignite rate fear and flip leadership to defensives.
- Overall market stance: Selective — broadening participation supports risk, but regime remains Cautious; avoid pure momentum without setup context.